Bioactive peptides are short amino acid sequences that lie dormant within the parent proteins of everyday foods. They do nothing while locked inside the protein chain, but once the protein is broken down by digestive enzymes, laboratory hydrolysis, or microbial fermentation, these fragments are released and can exert measurable physiological effects, from scavenging free radicals to lowering blood pressure and modulating the immune system. Whey, the liquid left over from cheese production, is a particularly attractive source because it makes up 15 to 20 percent of milk protein and is packed with essential amino acids such as leucine and cysteine, the latter serving as a building block of the antioxidant glutathione.

There is a catch, however. Whey proteins are highly hydrophobic and notoriously resistant to enzymatic hydrolysis, meaning that conventional commercial enzymes often fail to cut them at the right places to liberate their embedded bioactive sequences. The research team at Dankook University, led by Cheolhyun Kim, turned to an alternative strategy: fermentation with lactic acid bacteria strains that carry their own powerful proteolytic enzyme systems. Because these bacteria evolved to digest milk proteins as a nitrogen source, their enzyme cocktails can slice whey proteins in ways that commercial enzymes cannot, generating novel peptides at low production cost.

The researchers isolated ten bacterial strains from homemade dongchimi samples collected across South Korea. Using 16S rRNA gene sequencing, they identified eight strains of Leuconostoc mesenteroides, one strain of Pediococcus pentosaceus, and one strain of Latilactobacillus sakei, which they designated DC10. Dongchimi-derived strains were deliberately chosen because kimchi bacteria used in dairy fermentation can sometimes impart undesirable flavors, so the team pre-screened for strains with both probiotic potential and technological compatibility with dairy products. All ten isolates proved Gram-positive and survived artificial gastric juice at pH values between 1.5 and 3.0 as well as 24 hours of exposure to 0.3 percent oxgall bile, a robustness profile considered essential for probiotic applications.

When the strains were tested for proteolytic activity on skim milk agar, L. sakei DC10 stood out, producing a clear digestion zone wider than 23 millimeters, the largest among all ten isolates. The team then inoculated DC10, along with two L. mesenteroides strains, into a 10 percent whey protein concentrate solution and fermented it at 37 degrees Celsius for 20 hours. Using the TNBS colorimetric method to track free amino groups, they observed that the degree of hydrolysis climbed rapidly during the first four hours and plateaued after about 16 hours, confirming that the bacteria were actively cleaving peptide bonds throughout the fermentation.

Sodium dodecyl sulfate polyacrylamide gel electrophoresis provided a visual confirmation of the protein breakdown. Bands corresponding to the major whey components, including lactoferrin, bovine serum albumin, immunoglobulins, beta-lactoglobulin, and alpha-lactalbumin, appeared between 14 and 100 kilodaltons in the unfermented sample. After 16 hours of fermentation with DC10, the higher molecular weight proteins had largely disappeared, degraded into smaller fragments. The fermented solution was then passed through a preparative gel filtration column to separate the resulting peptides into distinct fractions by molecular weight.

Fraction 3 emerged as the star of the study. In calcium solubilization assays, it achieved roughly 85 percent calcium solubility, below the 93.67 percent of casein phosphopeptides, the industry-standard calcium carrier, but well above unhydrolyzed whey protein. Because casein phosphopeptides are relatively expensive, the researchers argue that whey-derived calcium-binding peptides could serve as a cost-effective alternative for calcium-fortified foods and nutraceuticals. Peptides typically chelate calcium through electron pairs on their amino and carboxyl groups, with side chains of leucine, aspartic acid, and glutamic acid stabilizing the complex, and amino acid profiling of Fraction 3 revealed high levels of branched-chain amino acids, which previous work links to enhanced calcium absorption and vitamin D receptor expression.

The antioxidant results were equally striking. In the ABTS radical scavenging assay, most fractions outperformed non-fermented whey protein, with Fraction 3 posting the highest value. Fractions 2 and 3 matched casein phosphopeptides in DPPH radical scavenging, and Fraction 3 actually exceeded the commercial standard in the FRAP iron-reduction assay, which measures the capacity to donate electrons and break free radical chain reactions. Mass spectrometry of Fraction 3 identified four fully sequenced peptides with molecular masses between 658 and 905 daltons, including TVQVTSTAV and SLVYPFPGPIHNSLPQ, sequences previously reported in the literature as antioxidative, antimicrobial, and immunomodulatory.

To probe anti-inflammatory activity, the team treated RAW 264.7 mouse macrophage cells with the peptide fractions and then provoked inflammation with lipopolysaccharide. MTT assays confirmed that all fractions preserved more than 80 percent cell viability, ruling out cytotoxicity as a confounding factor. The fractions inhibited nitric oxide production in a concentration-dependent manner, and enzyme-linked immunosorbent assays showed significant suppression of the pro-inflammatory cytokines IL-1 alpha, IL-6, and TNF-alpha compared with LPS-stimulated controls. Because TNF-alpha drives the activation of other inflammatory mediators, damping its expression may cascade into a broader reduction of the inflammatory response.

The authors caution that their findings rest on in vitro experiments, and they call for future studies to clarify the underlying molecular mechanisms, assess bioavailability in living organisms, and explore clinical applications. Even so, the work illustrates an elegant convergence of traditional food heritage and modern protein chemistry: bacteria from a centuries-old Korean radish ferment, selected for dairy compatibility, unlocking health-promoting fragments from a cheese-industry byproduct. If subsequent animal and human studies bear out the calcium, antioxidant, and immune benefits observed in the laboratory, dongchimi-derived fermentation could offer the food industry a low-cost route to multifunctional whey ingredients that simultaneously support bone health, oxidative balance, and immune regulation.

Subject of Research: Bioactive peptide production from whey protein fermented with lactic acid bacteria isolated from Korean dongchimi

Article Title: Functional characteristics of peptides from whey proteins fermented with lactic acid bacteria isolated from Dongchimi

Article References: Yoo, J., Lee, S., Song, S., & Kim, C. (2026). Functional characteristics of peptides from whey proteins fermented with lactic acid bacteria isolated from Dongchimi. Food Science of Animal Resources, 46(1), Article 50. https://doi.org/10.1007/s44463-025-00053-6

Image Credits: AI Generated

DOI: 10.1007/s44463-025-00053-6

Keywords: bioactive peptides, whey protein, lactic acid bacteria, dongchimi, fermentation, antioxidant activity, anti-inflammatory, calcium solubilization, Latilactobacillus sakei, functional foods, probiotics, food science

The research began with an ambitious screening campaign. The team collected lactic acid bacteria from several varieties of kimchi, ultimately isolating forty distinct bacterial candidates. Because kimchi is a naturally fermented ecosystem, its microbial residents are diverse, and not every lactic acid bacterium is a promising probiotic candidate. To narrow the field, the researchers employed a three-tier identification strategy. First, they used random amplified polymorphic DNA profiling, a genetic fingerprinting technique that distinguishes closely related isolates by generating strain-specific banding patterns. They then constructed phylogenetic trees based on the 16S ribosomal RNA gene, the standard molecular barcode for bacterial identification, and confirmed species identity with species-specific polymerase chain reaction assays targeting diagnostic marker sequences.

This molecular gauntlet winnowed the forty isolates down to three confirmed L. sakei strains, designated RKA, RKC, and TAB. The choice of species was deliberate. L. sakei has an interesting dual reputation: it is well known in the food industry as a bioprotective organism that can suppress spoilage and pathogenic bacteria in chilled meats, yet it is also increasingly studied as a probiotic candidate, with prior clinical work exploring its effects on conditions ranging from dry eye disease to knee osteoarthritis. Strains isolated from fermented foods are considered attractive probiotic sources because they are already adapted to survive in harsh, acidic, and competitive environments, conditions that resemble the journey through the human gastrointestinal tract.

That survival ability was precisely what the Gachon team set out to quantify. A candidate probiotic must endure stomach acid and bile salts if it is to reach the intestine alive. When the researchers exposed their strains to acidic conditions, survival ranged from 33 to 85 percent depending on the strain, while tolerance to bile salts fell between 49 and 68 percent. These are meaningful figures, indicating that a substantial fraction of cells could withstand simulated digestive stresses. The team also measured traits linked to the ability of bacteria to colonize the gut lining. Cell surface hydrophobicity, a proxy for adhesion to intestinal epithelial cells, ranged from 11.5 to 25.6 percent with ethyl acetate and from 21.0 to 47.4 percent with hexane, while auto-aggregation, the tendency of bacterial cells to clump together and form protective biofilms, spanned 12.6 to 44.0 percent across the three strains.

Safety evaluation is arguably the most critical gatekeeper in probiotic development, and here the researchers ran a battery of tests. Hemolytic activity, the ability of bacteria to rupture red blood cells, a hallmark of many pathogens, was assessed, and none of the strains displayed the gamma-hemolytic patterns that would raise concern. Antibiotic susceptibility testing, conducted according to established clinical standards, showed that the strains were sensitive to most of the antibiotics examined, including carbenicillin, clindamycin, chloramphenicol, ampicillin, erythromycin, and tetracycline. The one caveat is that the strains showed resistance to cefoxitin and metronidazole. The authors note that such intrinsic resistance patterns are not unusual among lactic acid bacteria, but antibiotic resistance profiles remain a standard item on the safety checklist that regulators and the International Scientific Association for Probiotics and Prebiotics expect candidates to clear before any human application.

Beyond survival and safety, the study probed the functional chemistry of the bacteria, focusing on their cell-free supernatants, the liquid fractions left behind after cells are removed, which contain the metabolites the bacteria secrete. These supernatants demonstrated notable antioxidant capacity, scavenging 34.1 to 37.9 percent of DPPH radicals and 41.6 to 43.1 percent of ABTS radicals in standard colorimetric assays. The crude preparations, which included cellular material, showed weaker activity, ranging from 3.9 to 8.7 percent for DPPH and 11.0 to 17.3 percent for ABTS. Importantly, the researchers backed up these biochemical observations with genetics, detecting the presence of sod and katA genes, which encode superoxide dismutase and catalase, enzymes central to neutralizing reactive oxygen species. All three strains also tolerated hydrogen peroxide at various concentrations, reinforcing the picture of organisms equipped with robust oxidative stress defenses.

Perhaps the most striking result concerned antimicrobial activity. The cell-free supernatant of strain RKC outperformed its counterparts, inhibiting the growth of an impressive roster of problematic microbes: Escherichia coli, Bacillus subtilis, Pseudomonas aeruginosa, Staphylococcus aureus, and even the fungal pathogen Candida albicans. This broad-spectrum antagonism likely reflects the production of organic acids, hydrogen peroxide, and possibly bacteriocins, ribosomally synthesized antimicrobial peptides that many lactic acid bacteria deploy against competitors. The finding resonates with a growing body of literature showing that kimchi-derived lactic acid bacteria can disrupt biofilms formed by foodborne pathogens on seafood and food processing surfaces, suggesting potential applications not only as dietary supplements but also as natural biopreservatives in the food industry.

To assess whether these bacterial products could pose a risk to human cells, the team tested both crude preparations and cell-free supernatants against Caco-2 cells, a widely used laboratory model derived from human colon adenocarcinoma that mimics the intestinal barrier. The results were reassuring: no significant cytotoxicity was observed. This is an essential data point, because a probiotic candidate that harms intestinal cells in vitro would be a non-starter regardless of its other virtues. Combined with the hemolysis and antibiotic susceptibility results, the cytotoxicity data build a preliminary but coherent safety profile for the three strains, positioning them as credible candidates for the next stages of evaluation.

The authors are careful to frame their findings as a starting point rather than a finish line. They explicitly call for genome-based characterization of the selected strains, which would involve whole-genome sequencing to identify virulence factors, functional gene clusters, and transferable antibiotic resistance genes at a resolution that phenotypic tests cannot match. Such genomic work has become the expected standard in modern probiotic research, and comparative analyses of L. sakei genomes are already revealing how niche adaptation, whether in meat, fish, or fermented vegetables, shapes the functional repertoire of this species. Until that deeper characterization is complete, the study stands as a rigorous demonstration that the tangy, spicy world of kimchi continues to yield microbes of genuine biotechnological interest, and that strain RKC, with its standout antimicrobial activity, may be the one to watch as the field moves from screening bench to functional food development.

Subject of Research: Probiotic potential of Latilactobacillus sakei strains isolated from kimchi

Article Title: Screening, isolation, and identification of Latilactobacillus sakei strains from kimchi with potential probiotic properties

Article References: Sharma, P., Sharma, A., & Lee, H.-J. (2026). Screening, isolation, and identification of Latilactobacillus sakei strains from kimchi with potential probiotic properties. 3 Biotech, 16(9), Article 405. https://doi.org/10.1007/s13205-026-04978-7

Image Credits: AI Generated

DOI: 10.1007/s13205-026-04978-7

Keywords: kimchi, Latilactobacillus sakei, probiotics, lactic acid bacteria, antimicrobial activity, antioxidant, gut microbiota, cell-free supernatant, 16S rRNA, food fermentation, Caco-2 cells, biopreservation